Categories Cannabis, Earnings

Neptune Wellness (NASDAQ: NEPT): Q3 2020 Earnings Snapshot

— Neptune Wellness Solutions Inc. (NASDAQ: NEPT) swung to a profit in the third quarter of 2020 from a loss last year, helped by a gain related to a reduction in the fair value of the contingent consideration in connection to SugarLeaf Labs purchase.

— Total revenues jumped by 40% year-over-year to CAD9.18 million. This was driven by the cannabis segment despite a decline in the nutraceutical segment.

Earnings Update by AlphaStreet

— Revenue from the cannabis segment reached CAD2.81 million. The company started the commercial operations of its Cannabis segment in March 2019.

— Revenue from the nutraceutical segment declined by 3% to CAD6.34 million.

— The adjusted EBITDA loss widened from last year, due to the investments made in the cannabis segment to grow the workforce in anticipation of increased sales volume as well as higher salaries and benefits at the corporate level.

— The company launched its hemp-derived wellness products, Forest Remedies and Ocean Remedies, in the US. A similar launch in Canada will be followed once approved by health authorities.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

BLK Earnings: BlackRock Q2 2024 profit jumps on higher revenues

Asset management company BlackRock, Inc. (NYSE: BLK) on Monday reported a double-digit increase in adjusted profit for the second quarter of 2024, aided by an 8% increase in revenues. Second-quarter

GS Earnings: All you need to know about Goldman Sachs’ Q2 2024 earnings results

The Goldman Sachs Group, Inc. (NYSE: GS) reported its second quarter 2024 earnings results today. Net revenues were $12.73 billion, up 17% compared to the same period a year ago,

Intuitive Surgical likely to report strong revenue, profit growth for Q2 2024

Intuitive Surgical, Inc. (NASDAQ: ISRG) is expected to report its second-quarter earnings next week, amid expectations for strong revenue and profit growth. The medical device maker is thriving on the

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top